Search
WGRX
WGRXAdd to Watchlist
0.084USD
-0.011-11.17%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
10.58MMarket Cap
LossP/E TTM
More Details of Wellgistics Health Inc Company
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
WGRX Info
Ticker SymbolWGRX
Company nameWellgistics Health Inc
IPO dateFeb 21, 2025
CEOMr. Brian Norton
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 21
Address3000 Bayport Drive Suite 950
CityTAMPA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33607
Phone18433021785
Websitehttps://wellgisticshealth.com/
Ticker SymbolWGRX
IPO dateFeb 21, 2025
CEOMr. Brian Norton
Company Executives of WGRX
Name
Name/Position
Position
Shareholding
Change
Mr. Nikul Panchal
Mr. Nikul Panchal
President, Healthcare Operations
President, Healthcare Operations
285.76K
--
Dr. Shafaat Pirani
Dr. Shafaat Pirani
Executive Vice President Healthcare Operations
Executive Vice President Healthcare Operations
102.08K
--
Mr. Howard Doss
Mr. Howard Doss
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Brett Thompson
Mr. Brett Thompson
Chief Technology Officer, Vice President - Technology
Chief Technology Officer, Vice President - Technology
--
--
Mr. Brett Bryant
Mr. Brett Bryant
Executive Vice President Supply Chain Operations
Executive Vice President Supply Chain Operations
--
--
Mr. Scott Madsen
Mr. Scott Madsen
Vice President - Finance
Vice President - Finance
--
--
Mr. Doug Edmund, Esq.
Mr. Doug Edmund, Esq.
Director of Compliance
Director of Compliance
--
--
Mr. Prashant Patel
Mr. Prashant Patel
President, Director
President, Director
--
--
Mr. Surendra (Suren) Ajjarapu
Mr. Surendra (Suren) Ajjarapu
Chairman of the Board
Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Nikul Panchal
Mr. Nikul Panchal
President, Healthcare Operations
President, Healthcare Operations
285.76K
--
Dr. Shafaat Pirani
Dr. Shafaat Pirani
Executive Vice President Healthcare Operations
Executive Vice President Healthcare Operations
102.08K
--
Mr. Howard Doss
Mr. Howard Doss
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Brett Thompson
Mr. Brett Thompson
Chief Technology Officer, Vice President - Technology
Chief Technology Officer, Vice President - Technology
--
--
Mr. Brett Bryant
Mr. Brett Bryant
Executive Vice President Supply Chain Operations
Executive Vice President Supply Chain Operations
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
By BusinessUSD
Name
Revenue
Proportion
Product
21.87M
93.71%
Pharmacy Retail Sales
865.70K
3.71%
Third Party Logistics Services
603.42K
2.59%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
21.87M
93.71%
Pharmacy Retail Sales
865.70K
3.71%
Third Party Logistics Services
603.42K
2.59%
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Norton (Brian)
14.37%
Patel Prashant
9.09%
Ajjarapu (Surendra K)
8.67%
Gundlapalli (Annapurna)
7.06%
Patel Trust 2010
3.53%
Other
57.27%
Shareholders
Shareholders
Proportion
Norton (Brian)
14.37%
Patel Prashant
9.09%
Ajjarapu (Surendra K)
8.67%
Gundlapalli (Annapurna)
7.06%
Patel Trust 2010
3.53%
Other
57.27%
Shareholder Types
Shareholders
Proportion
Individual Investor
44.59%
Corporation
3.53%
Investment Advisor
0.87%
Investment Advisor/Hedge Fund
0.54%
Research Firm
0.09%
Venture Capital
0.08%
Hedge Fund
0.04%
Other
50.25%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
21
4.39M
0.84%
--
2026Q1
33
2.91M
2.30%
-2.14M
2025Q4
22
4.38M
4.88%
+2.74M
2025Q3
12
1.68M
1.67%
+1.29M
2025Q2
17
44.39M
61.78%
+3.05M
2025Q1
17
42.47M
81.14%
+39.99M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Norton (Brian)
18.20M
17.36%
--
--
Oct 01, 2025
Patel Prashant
6.52M
6.22%
--
--
Oct 01, 2025
Ajjarapu (Surendra K)
5.98M
5.7%
--
--
Oct 01, 2025
Gundlapalli (Annapurna)
8.94M
8.53%
--
--
Oct 01, 2025
Patel Trust 2010
4.47M
4.26%
--
--
Oct 01, 2025
Ajjarapu (Sandhya)
4.46M
4.26%
--
--
Oct 01, 2025
Canning (Tim)
750.00K
0.72%
--
--
Sep 25, 2025
Geode Capital Management, L.L.C.
487.38K
0.46%
+218.17K
+81.04%
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
